Evidence map›Paper›PMID 37274803›Full record

ReviewWorld journal of gastroenterology2023

Radiomics in colorectal cancer patients.

Riccardo Inchingolo, Cesare Maino, Roberto Cannella, Federica Vernuccio, Francesco Cortese, Michele Dezio, Antonio Rosario Pisani, Teresa Giandola, Marco Gatti, Valentina Giannini and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Riccardo InchingoloUnit of Interventional Radiology, F. Miulli Hospital, Acquaviva delle Fonti 70021, Italy. riccardoin@hotmail.it.
Cesare MainoDepartment of Radiology, Fondazione IRCCS San Gerardo dei Tintori, Monza 20900, Italy.
Roberto CannellaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo 90127, Italy.
Federica VernuccioInstitute of Radiology, University Hospital of Padova, Padova 35128, Italy.
Francesco CorteseUnit of Interventional Radiology, F. Miulli Hospital, Acquaviva delle Fonti 70021, Italy.
Michele DezioUnit of Interventional Radiology, F. Miulli Hospital, Acquaviva delle Fonti 70021, Italy.
Antonio Rosario PisaniInterdisciplinary Department of Medicine, Section of Nuclear Medicine, University of Bari "Aldo Moro", Bari 70121, Italy.
Teresa GiandolaDepartment of Radiology, Fondazione IRCCS San Gerardo dei Tintori, Monza 20900, Italy.
Marco GattiDepartment of Surgical Sciences, University of Turin, Turin 10126, Italy.
Valentina GianniniDepartment of Surgical Sciences, University of Turin, Turin 10126, Italy.
Davide IppolitoDepartment of Radiology, Fondazione IRCCS San Gerardo dei Tintori, Monza 20900, Italy.
Riccardo FalettiDepartment of Surgical Sciences, University of Turin, Turin 10126, Italy.
University of Turin · ITAzienda Ospedaliera San Gerardo · ITOspedale Generale Regionale Francesco Miulli · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Bari Aldo Moro · ITUniversity of Padua · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main therapeutic options for colorectal cancer are surgical resection and adjuvant chemotherapy in non-metastatic disease. However, the evaluation of the overall adjuvant chemotherapy benefit in patients with a high risk of recurrence is challenging. Radiological images can represent a source of data that can be analyzed by using automated computer-based techniques, working on numerical information coded within Digital Imaging and Communications in Medicine files: This image numerical analysis has been named "radiomics". Radiomics allows the extraction of quantitative features from radiological images, mainly invisible to the naked eye, that can be further analyzed by artificial intelligence algorithms. Radiomics is expanding in oncology to either understand tumor biology or for the development of imaging biomarkers for diagnosis, staging, and prognosis, prediction of treatment response and diseases monitoring and surveillance. Several efforts have been made to develop radiomics signatures for colorectal cancer patient using computed tomography (CT) images with different aims: The preoperative prediction of lymph node metastasis, detecting

Indexed as

Artificial IntelligenceRectal NeoplasmsHumansLymphatic MetastasisMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesArtificial intelligenceColorectal cancerComputed tomographyLiver metastasesMagnetic resonance imagingPositron emission tomography/computed tomographyRadiomics

Identifiers

PMID37274803
PMCPMC10237092
OpenAlexW4376650825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.